NEW YORK (GenomeWeb) – Fluigent will distribute RAN Biotechnologies' products in Europe, RAN announced today.

RAN is a provider of chemicals for microfluidic and biotech applications, including fluorosurfactants and microfluidic surface coatings for stabilizing water-in-oil emulsions for droplet microfluidics and encapsulating biological molecules, such as DNA, RNA, cells, and proteins. According to the Beverly, Mass.-based firm, droplet microfluidics is an alternative to lab-on-a-chip technology that is compatible with many chemicals and biological molecules.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.